Dallah Healthcare
دله الصحيةTechnical Analysis & Signals
Dallah Healthcare stock is experiencing a downtrend with negative signals in technical analysis.
Technical Analysis
The Relative Strength Index (RSI) at 39.0 indicates that the stock is in the oversold territory, suggesting weakness in momentum. Additionally, the negative MACD crossover reinforces the likelihood of a continued downtrend.
Support & Resistance Levels
The support level at 98.74 SAR is critical, as a break below it could lead to further declines. Meanwhile, the resistance level at 104.61 SAR serves as an important barrier to watch.
Volume Analysis
The current trading volume may indicate a lack of activity, reflecting diminished investor interest in the stock at this time. An increase in volume is expected if the stock begins to regain momentum.
Fundamental Factors
Fundamental factors show that the price-to-earnings (P/E) ratio at 23.1 indicates a relatively high valuation. Additionally, the dividend yield of 1.99% may not be attractive under current conditions.
Risk Factors
Potential risks include the continuation of the downtrend in the Saudi market overall, which could negatively impact the stock's performance. Additionally, the presence of bearish patterns such as bearish divergence increases uncertainty.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. Investors are advised to closely monitor support and resistance levels before making any decisions.
Financial Fundamentals
Price Data
Price Chart - Dallah Healthcare
4004Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Moderate TrendFinancial Summary
Valuation
- Market Cap
- 10.13B
- P/E Ratio
- 23.10
- P/B Ratio
- 2.40
- EPS (Earnings/Share)
- 4.34
Profitability
- Revenue
- 4.29B
- Net Income
- 442.98M
- Return on Equity (ROE)
- +10.30%
- Shares Outstanding
- 101.20M
Balance Sheet
- Total Assets
- 9.14B
- Total Debt
- 4.23B
- Debt/Equity
- 1.02
- Free Float %
- +43.0%
Dividends & Margins
- Dividend Yield
- +1.99%
- Dividend/Share
- 2.00
- Book Value
- 41.71
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
5 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2025 | 4.07B +26.9% | 538.27M +14.2% | 9.14B +38.2% | 3.93B +94.5% | 5.32 +14.2% |
| 2024 | 3.21B +8.9% | 471.20M +30.8% | 6.61B +5.9% | 2.02B +2.5% | 4.66 +30.9% |
| 2023 | 2.94B +18.3% | 360.12M +31.2% | 6.24B +26.9% | 1.97B -0.2% | 3.56 +31.4% |
| 2022 | 2.49B | 274.46M | 4.92B | 1.98B | 2.71 |
| 2021 | — | — | — | — | — |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
No news currently available for Dallah Healthcare
Sector Comparison
| Symbol | Name | Price | Change% |
|---|---|---|---|
| 4013 | Dr. Sulaiman Al Habib | 232.20 SAR | |
| 4002 | Mouwasat | 63.90 SAR | |
| 4004 | Dallah Healthcare | 100.10 SAR | |
| 4017 | Fakeeh Care | 34.30 SAR | |
| 4005 | CARE | 122.30 SAR | |
| 4018 | Almoosa | 117.70 SAR | |
| 4007 | Alhammadi | 25.16 SAR | |
| 4019 | SMC Healthcare | 15.87 SAR |
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-08-12
Risk Assessment
Risk Factors
Average True Range 3.8% of stock price
Trading volume near or above average
P/E ratio 23.1
Debt-to-equity ratio 1.02
ADX indicator at 24
High volatility and financial pressures requiring careful monitoring
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is Dallah Healthcare stock price today?
Dallah Healthcare (4004) stock price today is 100.10 SAR, declining by -0.50% compared to the previous session close. The 52-week price range is between 88.78 SAR and 154.64 SAR.
2 What is Dallah Healthcare stock valuation?
The automated analysis signal for Dallah Healthcare is "Sell" with 65% confidence. The P/E ratio is 23.1. The P/B ratio is 2.40.
3 Is Dallah Healthcare Shariah-compliant?
Yes, Dallah Healthcare (4004) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are Dallah Healthcare dividend distributions?
Dallah Healthcare has a dividend yield of 1.99%, with an estimated annual dividend of 2.00 SAR per share.
5 What is Dallah Healthcare weekly performance?
Dallah Healthcare performance over different time periods: weekly change -0.41%, monthly -4.30%, and year-to-date -18.95%. The stock is currently trading with a volume of 102,837 shares.
6 What is the target level for Dallah Healthcare?
According to automated analysis for Dallah Healthcare: Short-term target (1-2 weeks): 95.00 SAR. Support level: 98.74 SAR. Resistance level: 104.61 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.